Design, synthesis and evaluation of substituted phenylpropanoic acid derivatives as peroxisome proliferator-activated receptor (PPAR) activators: novel human PPARα-selective activators
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (1) , 77-80
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δProceedings of the National Academy of Sciences, 1997
- Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured CellsJournal of Biological Chemistry, 1995
- Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome ProliferatorsMolecular and Cellular Biology, 1995
- The synthesis of BRL 49653 - a novel and potent antihyperglycaemic agentBioorganic & Medicinal Chemistry Letters, 1994
- Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers.Proceedings of the National Academy of Sciences, 1993
- Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptorsNature, 1992
- Studies on Antidiabetic Agents. X. Synthesis and Biological Activities of Pioglitazone and Related Compounds.Chemical and Pharmaceutical Bulletin, 1991
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Studies on hindered phenols and analogs. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidationJournal of Medicinal Chemistry, 1989